Back
ESC Premium Access

Moderate to severe mitral regurgitation is associated with worse long term survival in patients undergoing TAVI

Session: Poster session 1 - Aortic valve disease
Topic: Surgery and intervention in valve disease
Speaker: Doctor K. Feldt (Stockholm, SE)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Kari Feldt

Karolinska University Hospital, Stockholm (Sweden)
0 follower

28 more presentations in this session

Aortic valve gradient and mortality in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis

Speaker: Doctor G. Witberg (Petah Tikva, IL)

Access
Abstract
Slides
Like
Thumbnail

Postprocedural pacemaker rate is related to implantation depth and calcium distribution pattern after Sapien 3 implantation

Speaker: Doctor V. Mauri (Cologne, DE)

Access
Abstract
Like
Thumbnail

Endothelial and platelet derived microparticles in patients undergoing transcatheter aortic valve implantation (TAVI)

Speaker: Doctor B. Wernly (Salzburg, AT)

Access
Abstract
Slides
Like
Thumbnail

The impact of the development of TAVI on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.

Speaker: Professor C. Bouleti (Poitiers, FR)

Access
Abstract
Slides
Like
Thumbnail

Treatment options in intermediate-high risk patients with aortic stenosis and renal disfunction: the european multicenter propensity match study comparing tavr versus conventional avr surgery

Speaker: Professor C. Muneretto (Brescia, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 1 - Aortic valve disease

Speakers: Doctor K. Feldt, Doctor G. Witberg, Doctor V. Mauri, Doctor B. Wernly, Professor C. Bouleti...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources